Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Template:SubstanceBox/Ketobemidone: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
← Older edit
>IJUSTPOPPEDAXAN
Added a lot of information about duration and dosage
>IJUSTPOPPEDAXAN
m Removed one letter
 
Line 55: Line 55:
     |OralROA_Bioavailability=[[Oral min bioavailability::17]]% - [[Oral max bioavailability::62]]%<ref>https://bok.fass.se/LIF/product?userType=0&nplId=19930507000075</ref> <!-- Refer to this tool to generate APA citations from DOI links: https://reftag.appspot.com/doiweb.py -->
     |OralROA_Bioavailability=[[Oral min bioavailability::17]]% - [[Oral max bioavailability::62]]%<ref>https://bok.fass.se/LIF/product?userType=0&nplId=19930507000075</ref> <!-- Refer to this tool to generate APA citations from DOI links: https://reftag.appspot.com/doiweb.py -->
     |OralROA_Microdose=
     |OralROA_Microdose=
     |OralROA_Threshold=[[Oral threshold dose::2.5]] -  [[Oral dose units::mg]]  
     |OralROA_Threshold=[[Oral threshold dose::2.5]] [[Oral dose units::mg]]  
     |OralROA_Light=[[Oral min light dose::2.5]] - [[Oral max light dose::5]] mg
     |OralROA_Light=[[Oral min light dose::2.5]] - [[Oral max light dose::5]] mg
     |OralROA_Common=[[Oral min common dose::10]] - [[Oral max common dose::15]] mg
     |OralROA_Common=[[Oral min common dose::10]] - [[Oral max common dose::15]] mg

Latest revision as of 15:57, 29 May 2021

SubstanceBox/Ketobemidone
Chemical Nomenclature
Common names Cliradon, Cymidon, Ketogan, Ketorax
Substitutive name Ketobemidone
Systematic name 1-[4-(3-Hydroxyphenyl)-1-methyl-4-piperidyl]propan-1-one
Class Membership
Psychoactive class Opioid
Chemical class Piperidine
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.



⇣ Oral
Dosage
Bioavailability 17% - 62%[1]
Threshold 2.5 mg
Light 2.5 - 5 mg
Common 10 - 15 mg
Strong 15 - 25 mg
Heavy 25 mg +
Duration
Total 3 - 5.5 hours
Onset 10 - 30 minutes




⇣ Rectal
Dosage
Bioavailability 44%[2]
Threshold 2 - mg
Light 2 - 4 mg
Common 7.5 - 11.5 mg
Strong 11.5 - 20 mg
Heavy 20 mg +
Duration
Total x - y hours
Onset x - y minutes




⇣ Intravenous
Dosage
Bioavailability 100%[citation needed]
Threshold x - mg
Light x - y mg
Common x - y mg
Strong x - y mg
Heavy x mg +
Duration
Total 2 - 3 hours
Onset 5 - 10 seconds

DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

  1. ↑ https://bok.fass.se/LIF/product?userType=0&nplId=19930507000075
  2. ↑ Wikipedia contributors. (2021, March 28). Ketobemidone. In Wikipedia, The Free Encyclopedia. Retrieved 20:57, May 28, 2021, from https://en.wikipedia.org/w/index.php?title=Ketobemidone&oldid=1014750378
Retrieved from "http://psy.st/w/index.php?title=Template:SubstanceBox/Ketobemidone&oldid=123713"